Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,167.17
1,097.03
1,249.03
773.69
594.19
593.17
500.92
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,167.17
1,097.03
1,249.03
773.69
594.19
593.17
500.92
Raw Material Cost
211.12
267.72
200.15
142.95
71.04
102.82
85.91
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
69.29
129.34
44.40
40.25
38.65
38.97
34.38
Selling and Distribution Expenses
322.55
325.37
322.08
323.31
239.95
295.34
220.99
Other Expenses
29.56
24.29
31.44
28.34
22.65
26.12
23.65
Total Expenditure (Excl Depreciation)
898.54
965.32
881.04
789.89
576.11
698.33
577.82
Operating Profit (PBDIT) excl Other Income
268.6
131.7
368
-16.200000000000003
18.1
-105.19999999999999
-76.9
Other Income
22.30
23.27
19.19
36.35
37.86
20.44
38.89
Operating Profit (PBDIT)
304.49
168.49
400.98
34.09
70.35
-70.55
-24.03
Interest
69.29
129.34
44.40
40.25
38.65
38.97
34.38
Exceptional Items
0.00
135.49
-103.81
-15.26
-58.89
-70.27
-36.27
Gross Profit (PBDT)
956.05
829.31
1,048.87
630.74
523.15
490.35
415.01
Depreciation
13.55
13.51
13.80
13.94
14.40
14.17
13.98
Profit Before Tax
221.65
161.14
238.97
-35.36
-41.60
-193.96
-108.66
Tax
15.66
-25.28
-12.12
30.92
15.88
-110.19
2.91
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
205.99
186.42
251.08
-66.28
-57.48
-83.76
-111.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
205.99
186.42
251.08
-66.28
-57.48
-83.76
-111.57
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
205.99
186.42
251.08
-66.28
-57.48
-83.76
-111.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
1,075.38
789.18
233.89
250.59
115.44
67.09
32.35
Earnings per share (EPS)
1.51
1.37
1.84
-0.51
-0.44
-0.65
-0.87
Diluted Earnings per share
1.51
1.37
1.84
-0.51
-0.44
-0.65
-0.87
Operating Profit Margin (Excl OI)
23.02%
12.01%
29.46%
-2.09%
3.04%
-17.73%
-15.35%
Gross Profit Margin
20.15%
15.92%
20.24%
-2.77%
-4.58%
-30.31%
-18.9%
PAT Margin
17.65%
16.99%
20.1%
-8.57%
-9.67%
-14.12%
-22.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 6.40% vs -12.17% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 10.52% vs -25.77% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 94.35% vs -61.97% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -46.40% vs 191.22% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Alnylam Pharmaceuticals, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
1,167.17
944.96
222.21
23.52%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,167.17
944.96
222.21
23.52%
Raw Material Cost
211.12
219.96
-8.84
-4.02%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
69.29
16.53
52.76
319.18%
Selling and Distribution Expenses
322.55
433.22
-110.67
-25.55%
Other Expenses
29.56
13.35
16.21
121.42%
Total Expenditure (Excl Depreciation)
898.54
803.21
95.33
11.87%
Operating Profit (PBDIT) excl Other Income
268.64
141.75
126.89
89.52%
Other Income
22.30
-0.32
22.62
7,068.75%
Operating Profit (PBDIT)
304.49
237.73
66.76
28.08%
Interest
69.29
16.53
52.76
319.18%
Exceptional Items
0.00
10.35
-10.35
-100.00%
Gross Profit (PBDT)
956.05
725.00
231.05
31.87%
Depreciation
13.55
96.30
-82.75
-85.93%
Profit Before Tax
221.65
135.25
86.40
63.88%
Tax
15.66
8.18
7.48
91.44%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
205.99
127.07
78.92
62.11%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
205.99
127.07
78.92
62.11%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
205.99
127.07
78.92
62.11%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
1,075.38
5,310.96
-4,235.58
-79.75%
Earnings per share (EPS)
1.51
0.54
0.97
179.63%
Diluted Earnings per share
1.51
0.54
0.97
179.63%
Operating Profit Margin (Excl OI)
23.02%
15.00%
0.00
8.02%
Gross Profit Margin
20.15%
24.50%
0.00
-4.35%
PAT Margin
17.65%
13.45%
0.00
4.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 116.72 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 6.40% vs -12.17% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 96.43% vs 20.21% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 20.60 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 10.52% vs -25.77% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 458.26% vs 12.75% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 28.22 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 94.35% vs -61.97% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 768.31% vs 208.70% in Mar 2025
Quarterly - Interest
Interest 6.93 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -46.40% vs 191.22% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 79.53% vs 9.35% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.02%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
